These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 89888)

  • 1. The effects of drug which destroy the sympathetic nervous system on the retrograde transport of nerve growth factor.
    Johnson EM; Macia RA; Andres RY; Bradshaw RA
    Brain Res; 1979 Aug; 171(3):461-72. PubMed ID: 89888
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduction by reserpine of the accumulation of retrogradely transported [125I]nerve growth factor in sympathetic neurons.
    Johnson EM; Blumberg HM; Costrini NV; Bradshaw RA
    Brain Res; 1979 Dec; 178(2-3):389-401. PubMed ID: 92350
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retrograde axonal transport in rat ileal mesenteric nerves. Characterization using intravenously administered 125I-nerve growth factor and effect of chemical sympathectomy.
    Schmidt RE; Yip HK
    Diabetes; 1985 Dec; 34(12):1222-9. PubMed ID: 2415413
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The retrograde axonal transport of nerve growth factor.
    Hendry IA; Stöckel K; Thoenen H; Iversen LL
    Brain Res; 1974 Mar; 68(1):103-21. PubMed ID: 4143411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protection from guanethidine-induced neuronal destruction by nerve growth factor: effect of NGF on immune function.
    Manning PT; Russell JH; Simmons B; Johnson EM
    Brain Res; 1985 Aug; 340(1):61-9. PubMed ID: 3161586
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment with 6-hydroxydopamine and colchicine decreases nerve growth factor levels in sympathetic ganglia and increases them in the corresponding target tissues.
    Korsching S; Thoenen H
    J Neurosci; 1985 Apr; 5(4):1058-61. PubMed ID: 2580066
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison between the retrograde axonal transport of nerve growth factor and tetanus toxin in motor, sensory and adrenergic neurons.
    Stöckel K; Schwab M; Thoenen H
    Brain Res; 1975 Nov; 99(1):1-16. PubMed ID: 52914
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Leukemia inhibitory factor and nerve growth factor are retrogradely transported and processed by cultured rat sympathetic neurons.
    Ure DR; Campenot RB
    Dev Biol; 1994 Apr; 162(2):339-47. PubMed ID: 7512056
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retrograde axonal transport of [125I]nerve growth factor in ileal mesenteric nerves in vitro: effect of streptozotocin diabetes.
    Schmidt RE; Grabau GG; Yip HK
    Brain Res; 1986 Jul; 378(2):325-36. PubMed ID: 2425904
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Specificity of retrograde transport of nerve growth factor (NGF) in sensory neurons: a biochemical and morphological study.
    Stoeckel K; Schwab M; Thoenen H
    Brain Res; 1975 May; 89(1):1-14. PubMed ID: 50114
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biological importance of retrograde axonal transport of nerve growth factor in adrenergic neurons.
    Paravicini U; Stoeckel K; Thoenen H
    Brain Res; 1975 Feb; 84(2):279-91. PubMed ID: 46156
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of the retrograde axonal transport of nerve growth factor on the morphology of adrenergic neurones.
    Hendry IA
    Brain Res; 1977 Oct; 134(2):213-23. PubMed ID: 70261
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of the retrograde transport of nerve growth factor (NGF) using high specific activity [125I] NGF.
    Johnson EM; Andres RY; Bradshaw RA
    Brain Res; 1978 Jul; 150(2):319-31. PubMed ID: 209849
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retrograde axonal transport of intravenously administered 125I-nerve growth factor in rats with streptozotocin-induced diabetes.
    Schmidt RE; Modert CW; Yip HK; Johnson EM
    Diabetes; 1983 Jul; 32(7):654-63. PubMed ID: 6345245
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ultrastructural and immunohistologic characterization of guanethidine-induced destruction of peripheral sympathetic neurons.
    Schmidt RE; Summerfield AL; Hickey WF
    J Neuropathol Exp Neurol; 1990 Mar; 49(2):150-67. PubMed ID: 2307981
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of chronic guanethidine treatment on vascular norepinephrine content in the neonatal domestic pig.
    Terris JM
    Life Sci; 1983 Aug; 33(8):719-23. PubMed ID: 6888189
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunosuppressive agents prevent guanethidine-induced destruction of rat sympathetic neurons.
    Manning PT; Russell JH; Johnson EM
    Brain Res; 1982 Jun; 241(1):131-43. PubMed ID: 6125238
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retrograde transport and steady-state distribution of 125I-nerve growth factor in rat sympathetic neurons in compartmented cultures.
    Ure DR; Campenot RB
    J Neurosci; 1997 Feb; 17(4):1282-90. PubMed ID: 9006972
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Binding, internalization, and retrograde transport of 125I-nerve growth factor in cultured rat sympathetic neurons.
    Claude P; Hawrot E; Dunis DA; Campenot RB
    J Neurosci; 1982 Apr; 2(4):431-42. PubMed ID: 7069465
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential susceptibility of prevertebral and paravertebral sympathetic ganglia to experimental injury.
    Schmidt RE; McAtee SJ; Plurad DA; Parvin CA; Cogswell BE; Roth KA
    Brain Res; 1988 Sep; 460(2):214-26. PubMed ID: 2906265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.